Name: CASI Pharmaceuticals, Inc. (CASI) Balance Sheet
Creator: FinSpry

CASI Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for CASI Pharmaceuticals, Inc. (CASI) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	13.47	30.77	47.11	38.70	57.06	54.25	85.12
Short-Term Investments	2.62	13.69	4.23	9.87	9.31	0.00	0.00
Cash & Short-Term Investments	16.09	30.77	51.34	48.57	66.37	54.25	85.12
Accounts Receivable	15.35	10.14	12.97	9.80	4.65	1.29	0.00
Inventory	5.25	15.88	6.14	1.91	1.36	4.54	0.28
Other Current Assets	2.89	2.56	2.98	1.69	1.65	3.20	0.00
Total Current Assets	39.58	59.34	73.42	61.97	74.03	64.70	92.57
Non-Current Assets
Property, Plant & Equipment (Net)	11.36	9.24	13.23	21.82	10.76	9.69	1.75
Long-Term Investments	1.91	1.69	7.46	40.13	29.44	0.00	0.00
Intangible Assets	0.24	1.84	1.06	12.20	13.21	0.00	0.00
Other Non-Current Assets	0.59	3.16	1.06	2.18	0.30	0.50	0.31
Total Non-Current Assets	13.90	15.92	22.81	76.33	53.71	37.91	20.85
Total Assets	53.67	75.27	96.23	138.30	127.73	102.61	113.41
Current Liabilities
Accounts Payable	2.72	16.73	3.29	2.22	3.26	7.95	2.37
Short-Term Debt	18.39	0.00	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	18.39	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	8.47	1.12	0.65	6.04	1.97	0.00	0.00
Deferred Revenue	2.47	2.54	2.62	0.06	0.00	0.00	0.00
Other Current Liabilities	3.18	1.87	0.65	3.81	0.52	0.00	0.00
Total Current Liabilities	36.45	16.73	17.01	13.19	7.98	7.95	3.87
Non-Current Liabilities
Long-Term Debt	2.54	18.90	0.48	1.11	0.00	0.00	0.00
Other Non-Current Liabilities	12.84	15.48	11.82	13.22	12.87	1.02	0.07
Total Non-Current Liabilities	15.37	34.38	12.30	17.15	13.83	1.02	0.07
Total Liabilities	51.82	51.10	29.30	30.34	24.16	8.97	3.95
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	1.24	0.00	0.00
Retained Earnings	-700.08	-660.82	-637.16	-605.64	-570.50	-523.91	-478.94
Accumulated Other Comprehensive Income	-1.77	-1.20	-0.70	1.95	0.59	-2.73	-1.23
Treasury Stock	9.60	-9.60	9.33	8.03	-8.03	-8.03	-8.03
Additional Paid-in Capital	713.30	695.79	691.77	696.22	658.25	606.69	596.71
Minority Interest	0.00	0.00	22.36	23.46	22.03	20.67	0.00
Shares Outstanding	15.49	13.38	13.46	13.98	0.00	0.00	0.00
Total Stockholders' Equity	1.85	24.17	44.57	107.96	103.57	93.67	109.46
Total Liabilities & Equity	53.67	75.27	96.23	138.30	127.73	102.61	113.41